Literature DB >> 2909304

"Reperfusion injury" by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow.

K Przyklenk1, R A Kloner.   

Abstract

Do oxygen-derived free radicals, generated at the time of reperfusion, lethally injure viable, previously ischemic myocardium, damage vascular endothelium, and impair recovery of postischemic contractile function? To address these issues, 23 anesthetized open-chest dogs underwent 2 hours of left anterior descending coronary artery occlusion followed by 4 hours of reperfusion. Immediately prior to reflow, each dog was randomized to receive either the free radical scavenging agents superoxide dismutase (SOD) + catalase, or saline alone. SOD + catalase had no significant beneficial effect on infarct size measured by triphenyltetrazolium staining: area of necrosis averaged 38.5 +/- 6.1% vs. 46.3 +/- 6.2% of the area at risk in treated compared with control animals respectively (p = NS). Furthermore, infusion of SOD + catalase did not alter contractile function of the viable subepicardium: mean segment shortening (measured using sonomicrometry) at 4 hours postreperfusion was -23 +/- 5% of baseline, preocclusion values in controls dogs and -24 +/- 9% of preocclusion values in animals that received the scavenging agents. However, SOD + catalase treatment preserved the endocardial microvasculature (assessed by semiquantitative electron microscopic analysis) and enhanced regional myocardial blood flow after reperfusion. Specifically, mean score for microvascular injury was 0.41 +/- 0.14 vs. 0.10 +/- 0.08 (p less than 0.05) in control compared with SOD + catalase treated groups, and blood flow averaged 0.56 +/- 0.11 vs. 1.27 +/- 0.33 ml/min/g tissue (p less than 0.05), respectively, in the previously ischemic endocardium at 2 hours postreflow. Thus, SOD + catalase given at the time of reperfusion had no acute beneficial effect on either the extent of myocyte necrosis or postischemic contractile function in this canine model. SOD + catalase did, however, attenuate both endocardial vascular injury and the "low reflow" phenomenon. These data suggest that microvascular injury and low reflow following prolonged (2 hour) but transient coronary occlusion may be mediated by oxygen-derived free radicals generated at the time of reperfusion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2909304     DOI: 10.1161/01.res.64.1.86

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  35 in total

1.  The Open Artery Hypothesis: Past, Present, and Future.

Authors:  M Goel; J T Dodge; M Rizzo; C McLean; K A Ryan; W L Daley; C P Cannon; C M Gibson
Journal:  J Thromb Thrombolysis       Date:  1998-05       Impact factor: 2.300

2.  Existence and Clinical Relevance of Lethal Myocardial "Reperfusion Injury"

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

3.  Lethal "Reperfusion Injury": Is It a Real Entity?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

4.  Lethal Myocardial Reperfusion Injury: Does it Exist, Should We Treat It?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

5.  Little Evidence for Lethal Reperfusion Injury to Cardiomyocytes.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

Review 6.  The "no-reflow" phenomenon: basic science and clinical correlates.

Authors:  Thorsten Reffelmann; Robert A Kloner
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

7.  Reperfusion Injury: Basic Concepts and Protection Strategies.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

8.  Intracoronary infusion of superoxide dismutase and reperfusion injury in the pig heart.

Authors:  D Garcia-Dorado; P Théroux; J Alonso; J Elizaga; J Botas; F Fernandez-Avilés; J Soriano; R Munoz; J Solares
Journal:  Basic Res Cardiol       Date:  1990 Nov-Dec       Impact factor: 17.165

9.  Decrease of myocardial infarct size with desferrioxamine: possible role of oxygen free radicals in its ameliorative effect.

Authors:  K Chopra; M Singh; N Kaul; K I Andrabi; N K Ganguly
Journal:  Mol Cell Biochem       Date:  1992-07-06       Impact factor: 3.396

Review 10.  A role for pericytes in coronary no-reflow.

Authors:  Fergus M O'Farrell; David Attwell
Journal:  Nat Rev Cardiol       Date:  2014-04-29       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.